← SynDRA
PYRIDOSTIGMINE
SynDRA canonical compound SYN0003816 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ACHE |
|---|
| Mechanism of action | Cholinesterase inhibitor |
|---|
| Indication | myasthenia gravis |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- Cholinesterase inhibitor
- ACHE INHIBITOR
- Acetylcholinesterase inhibitor
- BCHE INHIBITOR
- F10 INHIBITOR
Drug classes
- Cholinesterase Inhibitors
- Cholinergic Agents
- Enzyme Inhibitors
- Neurotransmitter Agents
- Cholinesterase Inhibitor
ATC classes
- N07A · PARASYMPATHOMIMETICS
Cross-references
Synonyms
- pyridostigmine bromide
- pyridostigmine iodide
- Pyridostigmine cation
- Pyridostigmine ion
- Pyridostigminum
- Pyridostigmine Bromine
- Mestinon (TN)
- Mestinon-SR
- Regonol (TN)
- AQ-776/42801589
- Pyridinium, 3-hydroxy-1-methyl-, dimethylcarbamate (ester)
- Pyridinium, 3-(((dimethylamino)carbonyl)oxy)-1-methyl-(9CI)
- (1-methylpyridin-1-ium-3-yl) N,N-dimethylcarbamate
- 1-methyl-3-pyridiniumyl dimethylcarbamate
- 3-(((Dimethylamino)carbonyl)oxy)-1-methylpyridinium
- mestinon
- 3-((DIMETHYLCARBAMOYL)OXY)-1-METHYLPYRIDINIUM
- Pyridinium, 3-(((dimethylamino)carbonyl)oxy)-1-methyl-
- 3-((Dimethylcarbamoyl)oxy)-1-methylpyridin-1-ium
- 3-[(dimethylcarbamoyl)oxy]-1-methylpyridin-1-ium
- RefChem:55945
- DTXCID3088277
- BRN 1428269
- UNII-19QM69HH21
- Spectrum_001603
- Spectrum2_000861
- Spectrum3_001909
- Spectrum5_001046
- Lopac-P-9797
- SCHEMBL1317
- Lopac0_001035
- BSPBio_003478
- KBioSS_002083
- 5-21-02-00078 (Beilstein Handbook Reference)
- BIDD:GT0384
- DivK1c_000207
- PYRIDOSTIGMINE [VANDF]
- SPBio_000901
Reported adverse events
- Amblyopia
- Death
- Epistaxis
- Headache
- Myalgia
- Neck pain
- Vomiting
Look up PYRIDOSTIGMINE in the interactive SynDRA portal →